Refractory Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia Secondary to Immunotherapy Requiring Prolonged Immunosuppression

JCO Oncol Pract. 2020 Oct;16(10):699-700. doi: 10.1200/OP.20.00047. Epub 2020 Jun 30.

Authors

Mathew Hall¹, Nicholas Meti¹, Larissa Liontos^{1

2}, Matthew C Cheung^{1

2}, Sonal Gandhi^{1

2}

Affiliations

¹ University of Toronto, Toronto, Ontario, Canada.
² Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

PMID: 32603256
DOI: 10.1200/OP.20.00047

No abstract available

MeSH terms

Anemia, Hemolytic, Autoimmune* / therapy
Humans
Immunologic Factors
Immunosuppression Therapy / adverse effects
Immunotherapy
Red-Cell Aplasia, Pure* / chemically induced
Red-Cell Aplasia, Pure* / therapy

Substances

Immunologic Factors